» Articles » PMID: 23593460

Functional Deficits in PAK5, PAK6 and PAK5/PAK6 Knockout Mice

Overview
Journal PLoS One
Date 2013 Apr 18
PMID 23593460
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

The p21-activated kinases are effector proteins for Rho-family GTPases. PAK4, PAK5, and PAK6 are the group II PAKs associated with neurite outgrowth, filopodia formation, and cell survival. Pak4 knockout mice are embryonic lethal, while Pak5, Pak6, and Pak5/Pak6 double knockout mice are viable and fertile. Our previous work found that the double knockout mice exhibit locomotor changes and learning and memory deficits. We also found some differences with Pak5 and Pak6 single knockout mice and the present work further explores the potential differences of the Pak5 knockout and Pak6 knockout mice in comparison with wild type mice. The Pak6 knockout mice were found to weigh significantly more than the other genotypes. The double knockout mice were found to be less active than the other genotypes. The Pak5 knockout mice and the double knockout mice performed worse on the rotorod test. All the knockout genotypes were found to be less aggressive in the resident intruder paradigm. The double knockout mice were, once again, found to perform worse in the active avoidance assay. These results indicate, that although some behavioral differences are seen in the Pak5 and Pak6 single knockout mice, the double knockout mice exhibit the greatest changes in locomotion and learning and memory.

Citing Articles

PAK6 rescues pathogenic LRRK2-mediated ciliogenesis and centrosomal cohesion defects in a mutation-specific manner.

Iannotta L, Fasiczka R, Favetta G, Zhao Y, Giusto E, DallAra E Cell Death Dis. 2024; 15(10):752.

PMID: 39419978 PMC: 11487180. DOI: 10.1038/s41419-024-07124-4.


Human stem cell-based models to study synaptic dysfunction and cognition in schizophrenia: A narrative review.

Santarriaga S, Gerlovin K, Layadi Y, Karmacharya R Schizophr Res. 2023; 273:78-97.

PMID: 36925354 PMC: 10500041. DOI: 10.1016/j.schres.2023.02.029.


The Use of Nanomedicine to Target Signaling by the PAK Kinases for Disease Treatment.

Wang Y, Minden A Cells. 2021; 10(12).

PMID: 34944073 PMC: 8700304. DOI: 10.3390/cells10123565.


Neurobiology: Resetting the axon's batteries.

Twiss J, Kalinski A, Sahoo P, Dalla Costa I, Giger R Curr Biol. 2021; 31(14):R914-R917.

PMID: 34314722 PMC: 10069667. DOI: 10.1016/j.cub.2021.06.014.


Loss of p21-activated kinase Mbt/PAK4 causes Parkinson-like phenotypes in Drosophila.

Putz S, Kram J, Rauh E, Kaiser S, Toews R, Lueningschroer-Wang Y Dis Model Mech. 2021; 14(6).

PMID: 34125184 PMC: 8246267. DOI: 10.1242/dmm.047811.


References
1.
Sells M, Chernoff J . Emerging from the Pak: the p21-activated protein kinase family. Trends Cell Biol. 1997; 7(4):162-7. DOI: 10.1016/S0962-8924(97)01003-9. View

2.
Nekrasova T, Jobes M, Ting J, Wagner G, Minden A . Targeted disruption of the Pak5 and Pak6 genes in mice leads to deficits in learning and locomotion. Dev Biol. 2008; 322(1):95-108. DOI: 10.1016/j.ydbio.2008.07.006. View

3.
Soosairajah J, Maiti S, Wiggan O, Sarmiere P, Moussi N, Sarcevic B . Interplay between components of a novel LIM kinase-slingshot phosphatase complex regulates cofilin. EMBO J. 2005; 24(3):473-86. PMC: 548651. DOI: 10.1038/sj.emboj.7600543. View

4.
Li X, Minden A . Targeted disruption of the gene for the PAK5 kinase in mice. Mol Cell Biol. 2003; 23(20):7134-42. PMC: 230317. DOI: 10.1128/MCB.23.20.7134-7142.2003. View

5.
Lee S, Ramos S, Ko A, Masiello D, Swanson K, Lu M . AR and ER interaction with a p21-activated kinase (PAK6). Mol Endocrinol. 2002; 16(1):85-99. DOI: 10.1210/mend.16.1.0753. View